Bococizumab Biosimilar - Anti-PCSK9 Antibody - Low endotoxin, Azide free (A323327)

Bococizumab Biosimilar - Anti-PCSK9 Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to PCSK9.

ELISA, FACS, Functional Assay, In Vivo

Human, Mouse, Cynomolgus Macaque

Humanized

Monoclonal

IgG2SA - Human IgG2 with S387A mutation

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

> 90% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Convertase subtilisin/kexin type 9 preproprotein, FH3, HCHOLA3, Hypercholesterolemia autosomal dominant 3, LDLCQ1, NARC 1, NARC-1, NARC1, Neural apoptosis regulated convertase 1, Neural apoptosis-regulated convertase 1, PC 9, PC9, PCSK 9, PCSK9_HUMAN, Proprotein convertase 9, Proprotein convertase PC9, Proprotein convertase subtilisin/kexin type 9, PSEC0052, Subtilisin/kexin like protease PC9, Subtilisin/kexin-like protease PC9